{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:00:25Z","timestamp":1791975625276,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["RO1DA057790"],"award-info":[{"award-number":["RO1DA057790"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM153437"],"award-info":[{"award-number":["R35GM153437"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57734-5","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:51:53Z","timestamp":1741881113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Structure-guided design of partial agonists at an opioid receptor"],"prefix":"10.1038","volume":"16","author":[{"given":"Balazs R.","family":"Varga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8549-0413","authenticated-orcid":false,"given":"Sarah M.","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"El Daibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saheem A.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-6228","authenticated-orcid":false,"given":"Jordy H.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-3440","authenticated-orcid":false,"given":"Jhoan","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9853-3347","authenticated-orcid":false,"given":"Kevin","family":"Appourchaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina L.","family":"Nazarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Kouvelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Shinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haylee R.","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shainnel O.","family":"Eans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8777-302X","authenticated-orcid":false,"given":"Elyssa B.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-2384","authenticated-orcid":false,"given":"Jonathan F.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-2976","authenticated-orcid":false,"given":"Amynah","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-4505","authenticated-orcid":false,"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9851-9342","authenticated-orcid":false,"given":"Jay P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2931-3823","authenticated-orcid":false,"given":"Susruta","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-3027","authenticated-orcid":false,"given":"Tao","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"57734_CR1","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","volume":"393","author":"C Blanco","year":"2019","unstructured":"Blanco, C. & Volkow, N. D. Management of opioid use disorder in the USA: present status and future directions. Lancet 393, 1760\u20131772 (2019).","journal-title":"Lancet"},{"key":"57734_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jnr.24680","volume":"100","author":"CM Cahill","year":"2022","unstructured":"Cahill, C. M. et al. Delta opioid receptor activation modulates affective pain and modality\u2010specific pain hypersensitivity associated with chronic neuropathic pain. J. Neurosci. Res. 100, 129\u2013148 (2022).","journal-title":"J. Neurosci. Res."},{"key":"57734_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fnmol.2020.00052","volume":"13","author":"B Quirion","year":"2020","unstructured":"Quirion, B., Bergeron, F., Blais, V. & Gendron, L. The Delta-Opioid receptor; a target for the treatment of pain. Front. Mol. Neurosci. 13, 52 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"57734_CR4","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/bph.12591","volume":"171","author":"AA Pradhan","year":"2014","unstructured":"Pradhan, A. A., Smith, M. L., Zyuzin, J. & Charles, A. Opioid receptor agonists inhibit migraine\u2010related hyperalgesia, aversive state and cortical spreading depression in mice. Br. J. Pharmacol. 171, 2375\u20132384 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"57734_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.103.061242","volume":"309","author":"EM Jutkiewicz","year":"2004","unstructured":"Jutkiewicz, E. M. et al. \u03b4-Opioid agonists: differential efficacy and potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) derivatives in sprague-dawley rats. J. Pharm. Exp. Ther. 309, 173\u2013181 (2004).","journal-title":"J. Pharm. Exp. Ther."},{"key":"57734_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.bbr.2014.10.029","volume":"278","author":"P Chu Sin Chung","year":"2015","unstructured":"Chu Sin Chung, P. et al. Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures. Behav. Brain Res. 278, 429\u2013434 (2015).","journal-title":"Behav. Brain Res."},{"key":"57734_CR7","doi-asserted-by":"publisher","first-page":"16459","DOI":"10.1523\/JNEUROSCI.3748-10.2010","volume":"30","author":"AA Pradhan","year":"2010","unstructured":"Pradhan, A. A. et al. Ligand-directed trafficking of the \u03b4-opioid receptor in vivo: two paths toward analgesic tolerance. J. Neurosci. 30, 16459\u201316468 (2010).","journal-title":"J. Neurosci."},{"key":"57734_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu, K. et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat. Chem. Biol. 13, 529\u2013536 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"57734_CR9","doi-asserted-by":"crossref","unstructured":"Yajima, Y. et al. Modulation of NMDA- and (+)TAN-67-induced nociception by GABA(B) receptors in the mouse spinal cord. Life Sci. 68, 719\u201325 (2000).","DOI":"10.1016\/S0024-3205(00)00975-9"},{"key":"57734_CR10","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1523\/JNEUROSCI.5345-11.2012","volume":"32","author":"CK Nielsen","year":"2012","unstructured":"Nielsen, C. K. et al. \u03b4-Opioid Receptor Function in the Dorsal Striatum Plays a Role in High Levels of Ethanol Consumption in Rats. J. Neurosci. 32, 4540\u20134552 (2012).","journal-title":"J. Neurosci."},{"key":"57734_CR11","doi-asserted-by":"crossref","unstructured":"Yajima, Y. et al. Effects of differential modulation of \u03bc-, \u03b4- and \u03ba-opioid systems on bicuculline-induced convulsions in the mouse. Brain Res. 862, 120\u20136 (2000).","DOI":"10.1016\/S0006-8993(00)02096-5"},{"key":"57734_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/jpet.119.258640","volume":"372","author":"AE Conibear","year":"2020","unstructured":"Conibear, A. E. et al. A novel G protein\u2013biased agonist at the \u03b4 opioid receptor with analgesic efficacy in models of chronic pain. J. Pharm. Exp. Ther. 372, 224\u2013236 (2020).","journal-title":"J. Pharm. Exp. Ther."},{"key":"57734_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s40263-020-00738-0","volume":"34","author":"MJ Fossler","year":"2020","unstructured":"Fossler, M. J. et al. A phase I, randomized, single\u2011blind, placebo\u2011controlled, single ascending dose study of the safety, tolerability, and pharmacokinetics of subcutaneous and oral TRV250, a G protein-selective delta receptor agonist, in healthy subjects. CNS Drugs 34, 853\u2013865 (2020).","journal-title":"CNS Drugs"},{"key":"57734_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41586-022-05588-y","volume":"613","author":"A Faouzi","year":"2023","unstructured":"Faouzi, A. et al. Structure-based design of bitopic ligands for the \u00b5-opioid receptor. Nature 613, 767\u2013774 (2023).","journal-title":"Nature"},{"key":"57734_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-023-06030-7","volume":"617","author":"J Han","year":"2023","unstructured":"Han, J. et al. Ligand and G-protein selectivity in the \u03ba-opioid receptor. Nature 617, 417\u2013425 (2023).","journal-title":"Nature"},{"key":"57734_CR16","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029","volume":"186","author":"T Che","year":"2023","unstructured":"Che, T. & Roth, B. L. Molecular basis of opioid receptor signaling. Cell 186, 5203\u20135219 (2023).","journal-title":"Cell"},{"key":"57734_CR17","doi-asserted-by":"publisher","first-page":"eaaz3140","DOI":"10.1126\/scisignal.aaz3140","volume":"13","author":"A Gillis","year":"2020","unstructured":"Gillis, A. et al. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists. Sci. Signal. 13, eaaz3140 (2020).","journal-title":"Sci. Signal."},{"key":"57734_CR18","doi-asserted-by":"publisher","first-page":"13873","DOI":"10.1021\/acs.jmedchem.1c01273","volume":"64","author":"S Chakraborty","year":"2021","unstructured":"Chakraborty, S. et al. A novel mitragynine analog with low-efficacy mu opioid receptor agonism displays antinociception with attenuated adverse effects. J. Med. Chem. 64, 13873\u201313892 (2021).","journal-title":"J. Med. Chem."},{"key":"57734_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23736-2","volume":"12","author":"S Bhowmik","year":"2021","unstructured":"Bhowmik, S. et al. Site selective C\u2013H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy. Nat. Commun. 12, 3858 (2021).","journal-title":"Nat. Commun."},{"key":"57734_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.56519","volume":"10","author":"R Uprety","year":"2021","unstructured":"Uprety, R. et al. Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site. eLife 10, e56519 (2021).","journal-title":"eLife"},{"key":"57734_CR21","doi-asserted-by":"publisher","unstructured":"Ople, R. S. et al. Signaling modulation mediated by ligand water interactions with the sodium site at \u03bcOR. ACS Cent. Sci. https:\/\/doi.org\/10.1021\/acscentsci.4c00525 (2024).","DOI":"10.1021\/acscentsci.4c00525"},{"key":"57734_CR22","doi-asserted-by":"publisher","first-page":"769623","DOI":"10.3389\/fpsyt.2021.769623","volume":"12","author":"L Peris","year":"2021","unstructured":"Peris, L. & Szerman, N. Partial agonists and dual disorders: focus on dual schizophrenia. Front. Psychiatry 12, 769623 (2021).","journal-title":"Front. Psychiatry"},{"key":"57734_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","volume":"18","author":"JA Lieberman","year":"2004","unstructured":"Lieberman, J. A. Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 18, 251\u2013267 (2004).","journal-title":"CNS Drugs"},{"key":"57734_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/acschemneuro.2c00597","volume":"14","author":"MJ Cunningham","year":"2023","unstructured":"Cunningham, M. J. et al. Pharmacological mechanism of the non-hallucinogenic 5-HT 2A agonist ariadne and analogs. ACS Chem. Neurosci. 14, 119\u2013135 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"57734_CR25","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.str.2013.09.020","volume":"21","author":"H Guti\u00e9rrez-de-Ter\u00e1n","year":"2013","unstructured":"Guti\u00e9rrez-de-Ter\u00e1n, H. et al. The role of a sodium ion binding site in the allosteric modulation of the A2A adenosine G protein-coupled receptor. Structure 21, 2175\u20132185 (2013).","journal-title":"Structure"},{"key":"57734_CR26","doi-asserted-by":"publisher","first-page":"e92727","DOI":"10.1371\/journal.pone.0092727","volume":"9","author":"JL Miller-Gallacher","year":"2014","unstructured":"Miller-Gallacher, J. L. et al. The 2.1 \u00c5 resolution structure of cyanopindolol-bound \u03b21-Adrenoceptor identifies an intramembrane Na+ Ion that stabilises the ligand-free receptor. PLoS ONE 9, e92727 (2014).","journal-title":"PLoS ONE"},{"key":"57734_CR27","doi-asserted-by":"publisher","first-page":"eaax2518","DOI":"10.1126\/sciadv.aax2518","volume":"5","author":"A Luginina","year":"2019","unstructured":"Luginina, A. et al. Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs. Sci. Adv. 5, eaax2518 (2019).","journal-title":"Sci. Adv."},{"key":"57734_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1126\/science.aan5468","volume":"358","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. D 4 dopamine receptor high-resolution structures enable the discovery of selective agonists. Science 358, 381\u2013386 (2017).","journal-title":"Science"},{"key":"57734_CR29","doi-asserted-by":"crossref","unstructured":"Zarzycka, B., Zaidi, S. A., Roth, B. L. & Katritch, V. Harnessing ion-binding sites for GPCR pharmacology. Pharmacol. Rev. 71, 571\u2013595 (2019).","DOI":"10.1124\/pr.119.017863"},{"key":"57734_CR30","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1126\/science.182.4119.1359","volume":"182","author":"CB Pert","year":"1973","unstructured":"Pert, C. B., Pasternak, G. & Snyder, S. H. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182, 1359\u20131361 (1973).","journal-title":"Science"},{"key":"57734_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","volume":"39","author":"V Katritch","year":"2014","unstructured":"Katritch, V. et al. Allosteric sodium in class A GPCR signaling. Trends Biochem. Sci. 39, 233\u2013244 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"57734_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1126\/science.1219218","volume":"337","author":"W Liu","year":"2012","unstructured":"Liu, W. et al. Structural basis for allosteric regulation of GPCRs by sodium ions. Science 337, 232\u2013236 (2012).","journal-title":"Science"},{"key":"57734_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07939-8","volume":"10","author":"J Sch\u00f6ppe","year":"2019","unstructured":"Sch\u00f6ppe, J. et al. Crystal structures of the human neurokinin 1 receptor in complex with clinically used antagonists. Nat. Commun. 10, 17 (2019).","journal-title":"Nat. Commun."},{"key":"57734_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1124\/mol.114.095737","volume":"87","author":"A Massink","year":"2015","unstructured":"Massink, A. et al. Sodium ion binding pocket mutations and adenosine A 2A receptor function. Mol. Pharm. 87, 305\u2013313 (2015).","journal-title":"Mol. Pharm."},{"key":"57734_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29475-7","volume":"8","author":"S Capaldi","year":"2018","unstructured":"Capaldi, S. et al. Allosteric sodium binding cavity in GPR3: a novel player in modulation of A\u03b2 production. Sci. Rep. 8, 11102 (2018).","journal-title":"Sci. Rep."},{"key":"57734_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature12944","volume":"506","author":"G Fenalti","year":"2014","unstructured":"Fenalti, G. et al. Molecular control of \u03b4-opioid receptor signalling. Nature 506, 191\u2013196 (2014).","journal-title":"Nature"},{"key":"57734_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52601-1","volume":"15","author":"L Cheng","year":"2024","unstructured":"Cheng, L. et al. Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound. Nat. Commun. 15, 8284 (2024).","journal-title":"Nat. Commun."},{"key":"57734_CR38","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.1093\/nar\/gku316","volume":"42","author":"X Robert","year":"2014","unstructured":"Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320\u2013W324 (2014).","journal-title":"Nucleic Acids Res."},{"key":"57734_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"57734_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.neuropharm.2017.06.019","volume":"123","author":"EB Margolis","year":"2017","unstructured":"Margolis, E. B., Fujita, W., Devi, L. A. & Fields, H. L. Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor. Neuropharmacology 123, 420\u2013432 (2017).","journal-title":"Neuropharmacology"},{"key":"57734_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","volume":"16","author":"RHJ Olsen","year":"2020","unstructured":"Olsen, R. H. J. et al. TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome. Nat. Chem. Biol. 16, 841\u2013849 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"57734_CR42","doi-asserted-by":"publisher","first-page":"eaax9115","DOI":"10.1126\/sciadv.aax9115","volume":"5","author":"T Claff","year":"2019","unstructured":"Claff, T. et al. Elucidating the active \u03b4-opioid receptor crystal structure with peptide and small-molecule agonists. Sci. Adv. 5, eaax9115 (2019).","journal-title":"Sci. Adv."},{"key":"57734_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","volume":"186","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Structures of the entire human opioid receptor family. Cell 186, 413\u2013427.e17 (2023).","journal-title":"Cell"},{"key":"57734_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.str.2017.11.013","volume":"26","author":"ON Vickery","year":"2018","unstructured":"Vickery, O. N. et al. Intracellular transfer of Na+ in an active-state G-protein-coupled receptor. Structure 26, 171\u2013180.e2 (2018).","journal-title":"Structure"},{"key":"57734_CR45","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41586-023-05789-z","volume":"615","author":"F Sadler","year":"2023","unstructured":"Sadler, F. et al. Autoregulation of GPCR signalling through the third intracellular loop. Nature 615, 734\u2013741 (2023).","journal-title":"Nature"},{"key":"57734_CR46","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/prot.22927","volume":"79","author":"JE Donald","year":"2011","unstructured":"Donald, J. E., Kulp, D. W. & DeGrado, W. F. Salt bridges: geometrically specific, designable interactions. Proteins 79, 898\u2013915 (2011).","journal-title":"Proteins"},{"key":"57734_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s00213-002-1179-y","volume":"164","author":"D Broom","year":"2002","unstructured":"Broom, D. et al. Convulsant activity of a non-peptidic \u03b4-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology 164, 42\u201348 (2002).","journal-title":"Psychopharmacology"},{"key":"57734_CR48","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","volume":"27","author":"C Gav\u00e9riaux-Ruff","year":"2008","unstructured":"Gav\u00e9riaux-Ruff, C., Karchewski, L. A., Hever, X., Matifas, A. & Kieffer, B. L. Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur. J. Neurosci. 27, 2558\u20132567 (2008).","journal-title":"Eur. J. Neurosci."},{"key":"57734_CR49","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.3390\/molecules25184257","volume":"25","author":"A Faouzi","year":"2020","unstructured":"Faouzi, A., Varga, B. R. & Majumdar, S. Biased opioid ligands. Molecules 25, 4257 (2020).","journal-title":"Molecules"},{"key":"57734_CR50","doi-asserted-by":"publisher","first-page":"106961","DOI":"10.1016\/j.phrs.2023.106961","volume":"197","author":"N Ramos-Gonzalez","year":"2023","unstructured":"Ramos-Gonzalez, N., Paul, B. & Majumdar, S. IUPHAR themed review: Opioid efficacy, bias, and selectivity. Pharmacol. Res. 197, 106961 (2023).","journal-title":"Pharmacol. Res."},{"key":"57734_CR51","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41589-022-01208-y","volume":"19","author":"Q Qu","year":"2023","unstructured":"Qu, Q. et al. Insights into distinct signaling profiles of the \u00b5OR activated by diverse agonists. Nat. Chem. Biol. 19, 423\u2013430 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"57734_CR52","doi-asserted-by":"publisher","unstructured":"Varga, B. R., Streicher, J. M. & Majumdar, S. Strategies towards safer opioid analgesics\u2014A review of old and upcoming targets. Br. J. Pharmacol. https:\/\/doi.org\/10.1111\/bph.15760 (2022).","DOI":"10.1111\/bph.15760"},{"key":"57734_CR53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41589-022-01247-5","volume":"19","author":"AS Powers","year":"2023","unstructured":"Powers, A. S. et al. Structural basis of efficacy-driven ligand selectivity at GPCRs. Nat. Chem. Biol. 19, 805\u2013814 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"57734_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D: Biol. Crystallogr. 66, 213 (2010).","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"57734_CR55","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"57734_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D: Biol. Crystallogr. 66, 486 (2010).","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"57734_CR57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.str.2020.04.018","volume":"28","author":"MJ Robertson","year":"2020","unstructured":"Robertson, M. J., van Zundert, G. C. P., Borrelli, K. & Skiniotis, G. GemSpot: a pipeline for robust modeling of ligands into Cryo-EM maps. Structure 28, 707\u2013716.e3 (2020).","journal-title":"Structure"},{"key":"57734_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1107\/S2052252522000069","volume":"9","author":"JV Peck","year":"2022","unstructured":"Peck, J. V., Fay, J. F. & Strauss, J. D. High-speed high-resolution data collection on a 200 keV cryo-TEM. IUCrJ 9, 243\u2013252 (2022).","journal-title":"IUCrJ"},{"key":"57734_CR59","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"57734_CR60","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"57734_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. \u0131t MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. Sect. D."},{"key":"57734_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"57734_CR63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"57734_CR64","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/jcc.540150503","volume":"15","author":"R Abagyan","year":"1994","unstructured":"Abagyan, R., Totrov, M. & Kuznetsov, D. ICM\u2014A new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation. J. Comput Chem. 15, 488\u2013506 (1994).","journal-title":"J. Comput Chem."},{"key":"57734_CR65","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM\u2010GUI: a web\u2010based graphical user interface for CHARMM. J. Comput Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput Chem."},{"key":"57734_CR66","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.bpj.2021.02.029","volume":"120","author":"AN Leonard","year":"2021","unstructured":"Leonard, A. N. & Lyman, E. Activation of G-protein-coupled receptors is thermodynamically linked to lipid solvation. Biophys. J. 120, 1777\u20131787 (2021).","journal-title":"Biophys. J."},{"key":"57734_CR67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bpj.2008.09.042","volume":"96","author":"JH Davis","year":"2009","unstructured":"Davis, J. H., Clair, J. J. & Juhasz, J. Phase equilibria in DOPC\/DPPC-d62\/cholesterol mixtures. Biophys. J. 96, 521\u2013539 (2009).","journal-title":"Biophys. J."},{"key":"57734_CR68","doi-asserted-by":"publisher","first-page":"D370","DOI":"10.1093\/nar\/gkr703","volume":"40","author":"MA Lomize","year":"2012","unstructured":"Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370\u2013D376 (2012).","journal-title":"Nucleic Acids Res."},{"key":"57734_CR69","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997\u20132004 (2014).","journal-title":"J. Comput. Chem."},{"key":"57734_CR70","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"57734_CR71","doi-asserted-by":"publisher","unstructured":"Berendsen, H. J. C. Transport properties computed by linear response through weak coupling to a bath. In Computer Simulation in Materials Science: Interatomic Potentials, Simulation Techniques and Applications (eds. Meyer, M. & Pontikis, V.) 139\u2013155 https:\/\/doi.org\/10.1007\/978-94-011-3546-7_7 (Springer Netherlands, Dordrecht, 1991).","DOI":"10.1007\/978-94-011-3546-7_7"},{"key":"57734_CR72","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"key":"57734_CR73","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).","journal-title":"J. Chem. Phys."},{"key":"57734_CR74","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"57734_CR75","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","volume":"109","author":"RT McGibbon","year":"2015","unstructured":"McGibbon, R. T. et al. MDTraj: a modern open library for the analysis of molecular dynamics trajectories. Biophys. J. 109, 1528\u20131532 (2015).","journal-title":"Biophys. J."},{"key":"57734_CR76","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie Du Sert","year":"2020","unstructured":"Percie Du Sert, N. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 18, e3000410 (2020).","journal-title":"PLoS Biol."},{"key":"57734_CR77","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.3390\/molecules27113617","volume":"27","author":"LL Wilson","year":"2022","unstructured":"Wilson, L. L. et al. Characterization of CM-398, a novel selective sigma-2 receptor ligand, as a potential therapeutic for neuropathic pain. Molecules 27, 3617 (2022).","journal-title":"Molecules"},{"key":"57734_CR78","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3389\/fphar.2019.00678","volume":"10","author":"TJ Cirino","year":"2019","unstructured":"Cirino, T. J. et al. Characterization of sigma 1 receptor antagonist CM-304 and its analog, AZ-66: novel therapeutics against allodynia and induced pain. Front. Pharmacol. 10, 678 (2019).","journal-title":"Front. Pharmacol."},{"key":"57734_CR79","doi-asserted-by":"publisher","first-page":"764885","DOI":"10.3389\/fphar.2021.764885","volume":"12","author":"AM Gutridge","year":"2021","unstructured":"Gutridge, A. M. et al. Evaluation of kratom opioid derivatives as potential treatment option for alcohol use disorder. Front. Pharmacol. 12, 764885 (2021).","journal-title":"Front. Pharmacol."},{"key":"57734_CR80","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1021\/acs.jmedchem.8b01136","volume":"61","author":"NM Kennedy","year":"2018","unstructured":"Kennedy, N. M. et al. Optimization of a series of Mu opioid receptor (MOR) agonists with high G protein signaling bias. J. Med. Chem. 61, 8895\u20138907 (2018).","journal-title":"J. Med. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57734-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57734-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57734-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:30:47Z","timestamp":1741883447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57734-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57734"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57734-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4664764\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"30 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M. is a cofounder of Sparian biosciences. S.M., V.K., S.A.Z., T.C., J.P.M., and B.R.V. have filed patents on delta opioid bitopics developed in this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2518"}}